ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis

By D. Heijde, E. Lie, T. Kvien, J. Sieper, F. Bosch, J. Listing, J. Braun, R. Landewé. Annals of the Rheumatic Diseases, 2008

625 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis (2017, background): “55 87 Another argument is that increased ASDAS may lead to syndesmophyte formation, while this has not been proven for BASDAI alone (BASDAI works only if combined with CRP).”